nivolumab,bempegaldesleukin
bms,nektar
['gyn', 'bempeg', 'opdivo', 'bristol', 'nektar']
esmo : adding bempeg to opdivo lowered response rate in bristol myers-nektar failed cancer trial #oncologynews #oncology
Oncology-focused news, conference updates & opinion from @Larvol, the market-leading data & intelligence solution for the pharma & life-science industry.